A new TB vaccine for adolescents and adults, developed by IIT and ILS Bhubaneswar, is set for commercialisation.

“To address this critical unmet need, a next-generation HSP Subunit Vaccine has been developed through collaborative research ...

The vaccine triggers strong immune responses against Mycobacterium tuberculosis and is licensed for commercial development to ...

Bhubaneswar: The Bhubaneswar-based Indian Institute of Technology (IIT), the Institute of Life Sciences (ILS) along with the ...

Bhubaneswar and Institute of Life Sciences (ILS) along with National Research Development Corporation (NRDC) o ...

The HSP Subunit Vaccine candidate, jointly developed by the Institute of Life Sciences (ILS), Bhubaneswar, and the Indian Institute of Technology (IIT) Bhubaneswar, marks a significant advancement in ...

Bhubaneswar: The Bhubaneswar-based Indian Institute of Technology (IIT), the Institute of Life Sciences (ILS), along with the ...

Three Indian research institutes have signed an agreement with TechInvention Lifecare Limited for the technology transfer and future commercialisation of a novel TB vaccine candidate<br />The Indian ...

The Indian Institute of Technology and the Institute of Life Sciences, in partnership with TechInvention Lifecare and the National Research Development Corporation, are advancing a novel TB vaccine.

Tuberculosis (TB) remains one of the world’s deadliest infectious diseases, claiming 1.23 million lives in 2024 alone, as ...

The Bhubaneswar-based Indian Institute of Technology (IIT), the Institute of Life Sciences (ILS) along with the ...

A promising tuberculosis vaccine candidate, developed by ILS Bhubaneswar and IIT Bhubaneswar, has been transferred to ...